These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18678689)

  • 1. Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists.
    Thomas CP; Reif S; Haq S; Wallack SS; Hoyt A; Ritter GA
    Psychiatr Serv; 2008 Aug; 59(8):909-16. PubMed ID: 18678689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine for office-based practice: consensus conference overview.
    Kosten TR; Fiellin DA;
    Am J Addict; 2004; 13 Suppl 1():S1-7. PubMed ID: 15204671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency.
    Suzuki J; Connery HS; Ellison TV; Renner JA
    Am J Addict; 2014; 23(6):618-22. PubMed ID: 25065457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Office-based management of opioid dependence with buprenorphine: clinical practices and barriers.
    Walley AY; Alperen JK; Cheng DM; Botticelli M; Castro-Donlan C; Samet JH; Alford DP
    J Gen Intern Med; 2008 Sep; 23(9):1393-8. PubMed ID: 18592319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
    Rosenblatt RA; Andrilla CH; Catlin M; Larson EH
    Ann Fam Med; 2015; 13(1):23-6. PubMed ID: 25583888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences of a national sample of qualified addiction specialists who have and have not prescribed buprenorphine for opioid dependence.
    Kissin W; McLeod C; Sonnefeld J; Stanton A
    J Addict Dis; 2006; 25(4):91-103. PubMed ID: 17088229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.
    Molfenter T; Sherbeck C; Zehner M; Quanbeck A; McCarty D; Kim JS; Starr S
    Subst Abuse Treat Prev Policy; 2015 Mar; 10():13. PubMed ID: 25884206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C; Shum JH
    J Pain Palliat Care Pharmacother; 2004; 18(3):35-54. PubMed ID: 15364630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors affecting willingness to provide buprenorphine treatment.
    Netherland J; Botsko M; Egan JE; Saxon AJ; Cunningham CO; Finkelstein R; Gourevitch MN; Renner JA; Sohler N; Sullivan LE; Weiss L; Fiellin DA;
    J Subst Abuse Treat; 2009 Apr; 36(3):244-51. PubMed ID: 18715741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nurse practitioner and physician assistant interest in prescribing buprenorphine.
    Roose RJ; Kunins HV; Sohler NL; Elam RT; Cunningham CO
    J Subst Abuse Treat; 2008 Jun; 34(4):456-9. PubMed ID: 17664052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges in increasing access to buprenorphine treatment for opiate addiction.
    West JC; Kosten TR; Wilk J; Svikis D; Triffleman E; Rae DS; Narrow WE; Duffy FF; Regier DA
    Am J Addict; 2004; 13 Suppl 1():S8-16. PubMed ID: 15204672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.
    Tesema L; Marshall J; Hathaway R; Pham C; Clarke C; Bergeron G; Yeh J; Soliman M; McCormick D
    Subst Abus; 2018; 39(4):434-440. PubMed ID: 29513136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to primary care physicians prescribing buprenorphine.
    Hutchinson E; Catlin M; Andrilla CH; Baldwin LM; Rosenblatt RA
    Ann Fam Med; 2014; 12(2):128-33. PubMed ID: 24615308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attending physicians' and residents' attitudes and beliefs about prescribing buprenorphine at an urban teaching hospital.
    Cunningham CO; Sohler NL; McCoy K; Kunins HV
    Fam Med; 2006 May; 38(5):336-40. PubMed ID: 16673195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians as Mediators of Health Policy: Acceptance of Medicaid in the Context of Buprenorphine Treatment.
    Knudsen HK; Studts JL
    J Behav Health Serv Res; 2019 Jan; 46(1):151-163. PubMed ID: 30069622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Office-Based Buprenorphine Prescribers for Medicare Patients.
    Abraham R; Wilkinson E; Jabbarpour Y; Petterson S; Bazemore A
    J Am Board Fam Med; 2020; 33(1):9-16. PubMed ID: 31907241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.